PubMed Journals Articles About "Allergy Partners Explains Rhinitis Gets Respect" RSS

02:00 EDT 26th March 2019 | BioPortfolio

Allergy Partners Explains Rhinitis Gets Respect PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest Allergy Partners Explains Rhinitis Gets Respect articles that have been published worldwide.

More Information about "Allergy Partners Explains Rhinitis Gets Respect" on BioPortfolio

We have published hundreds of Allergy Partners Explains Rhinitis Gets Respect news stories on BioPortfolio along with dozens of Allergy Partners Explains Rhinitis Gets Respect Clinical Trials and PubMed Articles about Allergy Partners Explains Rhinitis Gets Respect for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Allergy Partners Explains Rhinitis Gets Respect Companies in our database. You can also find out about relevant Allergy Partners Explains Rhinitis Gets Respect Drugs and Medications on this site too.

Showing "Allergy Partners Explains Rhinitis Gets Respect" PubMed Articles 1–25 of 3,900+

Adherence to treatment in allergic rhinitis using mobile technology. the mask study.

Mobile technology may help to better understand the adherence to treatment MASK-rhinitis (Mobile Airways Sentinel NetworK for allergic rhinitis) is a patient-centered ICT system. A mobile phone app (the Allergy Diary) central to MASK is available in 22 countries.

Non-atopic Rhinitis at Age 6 is Associated with Subsequent Development of Asthma.

It has been postulated that the association between allergic rhinitis and asthma is attributable to the progressive clinical expression of respiratory inflammation during childhood. The role of non-allergic rhinitis in early life in relation to subsequent asthma has not been extensively explored.

Detection of Local Allergic Rhinitis in children with chronic, difficult-to-treat, non-allergic rhinitis using Multiple Nasal Provocation Tests.

There is little evidence on the incidence and characteristics of local allergic rhinitis (LAR) in children. Most studies have included subjects with perennial rhinitis only and results are based on the investigation of no more than three allergens per study. Our aim was to determine the proportion of children with LAR amongst children with chronic, difficult to treat, perennial or seasonal, rhinitis but no evidence of sensitization to aeroallergens, or other alternative diagnosis.

Impact of IgE sensitization and rhinitis on inflammatory biomarkers and lung function in adolescents with and without asthma.

Both allergic and non-allergic rhinitis are associated with worse asthma control. However, it is unclear how IgE sensitization and/or rhinitis are associated to lung function. We therefore evaluated the effect of rhinitis and sensitization on lung function, including the periphery of the airway system, and inflammatory biomarkers in individuals with and without asthma.

IgE Test in Secretions of Patients with Respiratory Allergy.

IgE is a key player in multiple inflammatory airway diseases. Ample literature demonstrates its presence in mucosa of patients with allergic rhinitis (AR), local allergic rhinitis (LAR), asthma, or chronic rhinosinusitis with nasal polyposis (CRSwNP).

More papers, more issues.

In recent years non-allergic rhinitis has received a lot of interest; in particular the different phenotypes, endotypes, the impact on quality of life and the potential role of IgE in local allergic rhinitis (LAR). The prevalence of LAR reported in the literature has been extremely variable (0-100%); Hamizan’s review in this issue explains many of these discrepancies. The overall prevalence of IgE in nasal secretion was found to be 10.2 (7.4-13.4) %. However, where there is history of an identifiable...

MiR-202-5p Promotes M2 Polarization in Allergic Rhinitis by Targeting MATN2.

The aim of this study was to investigate the effect of MiR-202-5p on macrophages involved in allergic rhinitis.

Non-allergic rhinitis with eosinophilic syndrome. Case report.

Rhinitis is the leading cause for consultation in the allergy department. It consists in chronic inflammation of the nasal mucosa. Non-allergic rhinitis with eosinophilic syndrome is characterized by chronic inflammation of the nasal mucosa (> 20% of eosinophils in nasal cytology) in the absence of demonstrable allergy (negative in vivo and in vitro tests); often it is accompanied by other sinonasal conditions (nasal polyposis, chronic rhinosinusitis), and it constitutes a risk factor for the development of...

Effects of aerobic exercise and vitamin C supplementation on rhinitis symptoms in allergic rhinitis patients.

Exercise training and vitamin C supplementation have both been recommended as an effective adjuvant treatment in the management of symptoms in patients with many diseases. However, its effects on rhinitis symptoms remain unclear. The aim of the present study was to determine the effects of exercise training alone, and in combination with vitamin C supplementation, on rhinitis symptoms in allergic rhinitis patients.

Intranasal Treatment With 1, 25-Dihydroxyvitamin D3 Alleviates Allergic Rhinitis Symptoms in a Mouse Model.

Vitamin D is a potent immunomodulator. However, its role in the pathogenesis of allergic rhinitis is unclear.

Recent Patents in Allergy/Immunology: Use of arginase inhibitors in the treatment of asthma and allergic rhinitis.

Asthma is a chronic inflammatory disease characterized by recurrent airways obstruction, airway hyperresponsiveness (AHR), airway inflammation and airway remodeling, which is often associated with allergy and allergic rhinitis. Many patients with asthma are poorly controlled by current drug treatment, particularly a subgroup of patients with difficult-to-treat severe asthma, characterized by chronic symptoms, severe exacerbations, progressive loss of lung function and resistance to corticosteroids. New ther...

Olopatadine/Mometasone Combination Nasal Spray Improves Seasonal Allergic Rhinitis Symptoms in an Environmental Exposure Chamber Study.

GSP301 nasal spray is a fixed-dose combination of the antihistamine olopatadine hydrochloride and the corticosteroid mometasone furoate intended for seasonal allergic rhinitis (SAR) treatment.

Allergic rhinitis and the associated risk of nocturnal enuresis in children: a nationwide population-based cohort study.

Despite controversy, an association between allergy and nocturnal enuresis (NE) has been reported for almost a century. Allergic rhinitis (AR)-associated sleep-disordered breathing frequently results in microarousals during sleep, decreased sleep efficiency, and change in sleep pattern and behavior. NE is a common sleep disorder in children. Hence, this study aimed to investigate the incidence and risk of NE in children with AR.

MP-AzeFlu provides rapid and effective allergic rhinitis control: results of a non-interventional study in Denmark.

Allergic rhinitis (AR) control is a priority in the European Union (EU), and Allergic Rhinitis and its Impact on Asthma (ARIA) has endorsed a visual analogue scale (VAS) as the new language of AR control. This study evaluated the effectiveness of MP-AzeFlu (Dymista®, antihistamine [azelastine], and intranasal corticosteroid [fluticasone propionate]) using a VAS in real-life clinical practice in Denmark.

Association of antimicrobial household exposure with development of allergic rhinitis in Korea.

Antimicrobial chemicals are used in consumer products. Typical antimicrobial chemicals include triclosan (TCS) and its congener troclocarban (TCC). TCS exhibits endocrine-disruptor activity and affects thyroid hormone and estrogen and androgen levels. Urinary TCS concentrations in children were associated with allergic sensitization, with higher TCS concentrations being associated with increased risk of current rhinitis. This article is protected by copyright. All rights reserved.

Patterns in Google Trends Terms Reporting Rhinitis and Ragweed Pollen Season in Ukraine.

Google Trends (GT) may represent a new approach to assessing pollen allergy. However, the development of a pan-European sentinel network has raised a problem of translating terms in different languages. A precise definition of the pollen season onset is crucial for the confirmation of a pollen allergy diagnosis and personalized treatment. Ragweed pollen allergy was investigated due to its high allergenicity and wide expansion in Europe.

A new molecular multiplex IgE assay for the diagnosis of pollen allergy in Mediterranean countries: a validation study.

The identification of the primary sensitizing pollen is difficult in Southern European patients with Seasonal Allergic Rhinitis (SAR) if sensitized to various pollen sources with overlapping seasonality. A more precise diagnosis is obtained by IgE assays to allergen molecules, currently available as singleplex or microarrays.

The Influence of Age on the Relationship Between Allergic Rhinitis and Otitis Media.

To examine the relationship between otitis media, allergic rhinitis, and age.

Comparison of regulatory B cells in asthma and allergic rhinitis.

Triamcinolone Acetonide versus Fluticasone Propionate in the Treatment of Perennial Allergic Rhinitis: A Randomized, Parallel-Group Trial.

Intranasal sprays are recommended as targeted therapy for allergic rhinitis (AR). Triamcinolone acetonide is a nasal corticosteroid preparation indicated for the treatment of seasonal and perennial AR (PAR) in different countries worldwide.

Nasal IgE Production in Allergic Rhinitis: Impact of Rhinovirus Infection.

Rhinovirus (RV) infections exacerbate asthma in part by enhancing an allergic state and these exacerbations can be mitigated via administration of anti-IgE.

Chronological changes in rhinitis symptoms present in school-aged children with allergic sensitization.

It is difficult to accurately predict the natural course of allergic rhinitis (AR), because it is affected by a wide variety of environmental influences, as well as genetic predisposition. Considering the high prevalence of allergic rhinitis in children and adolescents, caregivers should be given appropriate information regarding the disease course. This study aimed to understand the prognosis of allergic rhinitis by examining the relationship between allergic sensitization and rhinitis symptoms during this...

Alfred William (Bill) Frankland.

First double- blind, placebo - controlled trials in allergy: grass pollen immunotherapy proved effective. but bacterial vaccines lacked efficacy in asthma. First Secretary of BSACI. Instituted the UK pollen count. Antihistamine efficacy in allergic rhinitis, not asthma. Placebo response. Sub- epithelial eosinophils in asthmatic bronchi. Allergen and aspirin challenge studies in asthma, local allergy. This article is protected by copyright. All rights reserved.

Untreated allergic rhinitis is a major risk factor contributing to motorcar accidents.

The Characteristics of Severe Chronic Upper-Airway Disease (SCUAD) in Patients with Allergic Rhinitis: A Real-Life Multicenter Cross-Sectional Italian Study.

There are few studies regarding severe chronic upper-airway disease (SCUAD) that represents an important socioeconomic problem for the treatment of rhinitis and associated comorbidities, particularly asthma.

Quick Search